AI-driven scientific breakthroughs: Redefining antibiotics and the laboratories that power them

In a remarkable leap for medical science, Massachusetts Institute of Technology Researchers have developed a generative AI tool that can design entirely new antibiotics against drug-resistant superbugs – an approach that has already yielded two promising candidates. Although years of refinement and clinical trials lie ahead, the development could signal a “second golden age” in antibiotic discovery, creating a new dynamic for real estate needs.